Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (68)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Standeven, A. M.
Right arrow Articles by Wetterhahn, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Standeven, A. M.
Right arrow Articles by Wetterhahn, K. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

Ascorbate is the principal reductant of chromium(VI) in rat liver and kidney ultrafiltrates

Andrew M. Standeven and Karen E. Wetterhahn 1 2

Department of Pharmacology and Toxicology, Dartmouth Medical School Dartmouth College, Hanover, NH 03755, USA
1Department of Chemistry Dartmouth College Hanover, NH 03755, USA

2To whom correspondence should be addressed

Chromium(VI) reductase activity was measured in ultra-filtrates of rat liver and kidney after various pretreatments in vitro at 37°C and pH 7.0. Preincubation of ultrafiltrates with L-ascorbate oxidase (EC 1.10.3.3 [EC] ), which specifically eliminated ascorbate, blocked {small tilde}80% of the Cr(VI) reductase activity. Heat-denatured ascorbate oxidase had no effect on Cr(VI) reductase activity in ultrafiltrates. Preincubation of ultrafiltrates with N-ethylmaleimide, which non-specifically blocked sulfhydryls, including reduced glutathione, decreased Cr(VI) reductase activity by only 20%. Treatment of male Sprague-Dawley rats with phorone decreased non-protein sulfhydryl (NPSH) levels in rat liver by >90% and tripled reduced ascorbate levels 2 h after treatment. Ultrafiltrates of liver prepared from phorone-treated rats had twice the Cr(VI) reductase activity of control ultrafiltrates, and >95% of this activity could be blocked by preincubation with ascorbate oxidase. Treatment of rats with sodium dichromate (20 mg/kg) caused a significant decrease in ascorbate levels in kidney but not liver, and no change in NPSH levels in kidney or liver, 15 min after treatment. We conclude that ascorbate is the major reductant of Cr(VI) in rat liver and kidney ultrafiltrates and may well be the major non-enzymatic reductant of Cr(VI) in rat liver and kidney in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. Reynolds and A. Zhitkovich
Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53
Carcinogenesis, July 1, 2007; 28(7): 1613 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Quievryn, J. Messer, and A. Zhitkovich
Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate
Carcinogenesis, November 1, 2006; 27(11): 2316 - 2321.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. L. Carlisle, D. E. Pritchard, J. Singh, B. M. Owens, L. J. Blankenship, J. M. Orenstein, and S. R. Patierno
Apoptosis and P53 Induction in Human Lung Fibroblasts Exposed to Chromium (VI): Effect of Ascorbate and Tocopherol
Toxicol. Sci., May 1, 2000; 55(1): 60 - 68.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.-M. P. Yuann, K. J. Liu, J. W. Hamilton, and K. E. Wetterhahn
In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium–DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of Osteogenic Disorder Shionogi rats following treatment with chromium(VI)
Carcinogenesis, July 1, 1999; 20(7): 1267 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
M. Gao, L.S. Levy, R.A. Braithwaite, and S.S. Brown
Monitoring of Total Chromium in Rat Fluids and Lymphocytes Following Intratracheal Administration of Soluble Trivalent or Hexavalent Chromium Compounds
Human and Experimental Toxicology, January 1, 1993; 12(5): 377 - 382.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.